Author:
Zeng Jun,Huang Xin,Zhou Lina,Tan Yexiong,Hu Chunxiu,Wang Xiaomei,Niu Junqi,Wang Hongyang,Lin Xiaohui,Yin Peiyuan
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Kassahun, W. T., Fangmann, J., Harms, J., Hauss, J. & Bartels, M. Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant 4, 549–558 (2006).
2. Chen, T. L. et al. Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma. Mol. Cell. Proteomics 10, 10.1074/mcp.M110.004945 (2011).
3. El-Serag, H. B. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterology 142, 1264-+, 10.1053/j.gastro.2011.12.061 (2012).
4. Chen, J. G. & Zhang, S. W. Liver cancer epidemic in China: Past, present and future. Semin. Cancer Biol. 21, 59–69, 10.1016/j.semcancer.2010.11.002 (2011).
5. Schiffer, E. et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 41, 307–314, 10.1002/hep.20538 (2005).
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献